BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  Hospira Foundation Announces Launch Of (Mission: Care)2 Grant Challenge In Honor Of 10th Anniversary

  October 3, 2014

   · 

  2 min read
• Drug Development

  Receptos Announces First Patient Treated With Anti-Interleukin-13 Antibody In Phase 2 Trial For Eosinophilic Esophagitis

  October 3, 2014

   · 

  3 min read
• Drug Development

  Neurocrine Biosciences, Inc. Announces Expansion Of VMAT2 Inhibitor Program With Initiation Of Tourette Syndrome Clinical Study

  October 3, 2014

   · 

  6 min read
• ISPE Plan To Prevent Drug Shortages To Be Released October 14

  October 3, 2014

   · 

  3 min read
• Business

  ResMed Inc. To Announce First Quarter 2015 Results

  October 3, 2014

   · 

  1 min read
• Business

  AMPAC Fine Chemicals Partners With CHEMGO Organica AG Of Switzerland

  October 3, 2014

   · 

  1 min read
• BioMidwest

  Astellas Pharma Inc. Launches New Employee Benefits Program In Response To Multi-Generational Family Needs

  October 3, 2014

   · 

  3 min read
• Business

  Mylan Inc. Increases Third Quarter And Full Year 2014 Adjusted Diluted EPS Guidance Range

  October 3, 2014

   · 

  5 min read
• Genetown

  DecImmune Therapeutics Awarded $3 Million In SBIR Phase 2B Funding

  October 3, 2014

   · 

  1 min read
• Drug Development

  CEL-SCI Enrolls 16 Patients In September In Its Phase 3 Immunotherapy Head And Neck Cancer Trial

  October 3, 2014

   · 

  1 min read